β-catenin induces A549 alveolar epithelial cell mesenchymal transition during pulmonary fibrosis

Song,Ping; Zheng,Jin‑Xu; Xu,Jiao; Liu,Ji‑Zhu; Wu,Li‑Yan; Liu,Chao

doi:10.3892/mmr.2014.3013

β-catenin induces A549 alveolar epithelial cell mesenchymal transition during pulmonary fibrosis

Authors:
- Ping Song
- Jin‑Xu Zheng
- Jiao Xu
- Ji‑Zhu Liu
- Li‑Yan Wu
- Chao Liu
View Affiliations

Affiliations: Respiratory Department, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China, Respiratory Department, Huaibei Miner General Hospital, Huaibei, Anhui 235000, P.R. China
Published online on: November 27, 2014 https://doi.org/10.3892/mmr.2014.3013
Pages: 2703-2710

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease characterized by expansion of the fibroblast and myofibroblast population and extracellular matrix deposition. Although the pathogenic mechanisms of IPF remain to be fully elucidated, there is emerging evidence that fibroblasts and myofibroblasts may be derived partially from alveolar epithelial cells by epithelial‑mesenchymal transition (EMT). In the present study, A549 cells were treated with different concentrations of Wnt1 and the results indicated that the mRNA and protein expression levels of vimentin, α‑smooth muscle actin (α‑SMA) and collagen Ⅰ gradully increased and those of E‑cadherin gradully decreased in a concentration‑dependent manner. Furthermore, the A549 cells were transfected with β‑catenin plasmid cells, revealing phenotypic changes in the cells from a pebble to a fusiform shape. The mRNA and protein expression levels of of vimentin, α‑SMA and collagen Ⅰ increased significantly, whereas those of E‑cadherin decreased significantly. The present study examined the roles of alveolar epithelial cell injury and profibrogenic cytokine release in EMT and their association with the Wnt/β‑catenin signaling pathway in a mouse model of bleomycin‑induced pulmonary fibrosis. Bronchoalveolar fluid was obtained 7 days after treatment with bleomycin and the A549 cells were incubated for 48 h. An increase in the expression levels of the mesenchymal markers, α‑SMA, vimentin and collagen Ⅰ, and a concomitant decrease in the expression of the epithelial marker, E‑cadherin were observed. This corresponded with an increased expression of β‑catenin. When the A549 cells were infected with a lentivirus expressing β‑catenin shRNA, no significant increase was observed in the expression of the mesenchymal cell markers and the expression of E‑cadherin did not decrease. These findings demonstrated that activation of the Wnt signaling pathway was capable of inducing an EMT program in the lung epithelial cells through β‑catenin and that injured alveolar epithelium activated the Wnt/β‑catenin signaling pathway, thereby inducing the expansion of the fibroblast/myofibroblast population through EMT. These results suggested that β‑catenin was involved in the formation of lung fibrosis and may provide a theoretical basis for the treatment of IPF.

View Figures

View References

1	Kliment CR, Englert JM, Gochuico BR, et al: Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis. J Biol Chem. 284:3537–3545. 2009. View Article : Google Scholar :
2	Selman M and Pardo A: The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis. Am J Resp Cell Mol Bio. 29:S93–S97. 2003.
3	Ramos C, Becerril C, Montaño M, et al: FGF-1 reverts epithelial-mesenchymal transition induced by TGF-{beta}1 through MAPK/ERK kinase pathway. Am J Physiol Lung Cell Mol Physiol. 299:L222–L231. 2010. View Article : Google Scholar : PubMed/NCBI
4	Willis BC, Liebler JM, Luby-Phelps K, et al: Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-β1: potential role in idiopathic pulmonary fibrosis. Am J Pathol. 166:1321–1332. 2005. View Article : Google Scholar : PubMed/NCBI
5	Kim KK, Kugler MC, Wolters PJ, et al: Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA. 103:13180–13185. 2006. View Article : Google Scholar : PubMed/NCBI
6	Willis BC and Borok Z: TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. AM J Physiol Lung Cell Mol Physiol. 293:L525–L534. 2007. View Article : Google Scholar : PubMed/NCBI
7	Tanjore H, Xu XC, Polosukhin VV, et al: Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med. 180:657–665. 2009. View Article : Google Scholar : PubMed/NCBI
8	Selman M and Pardo A: Idiopathic pulmonary fibrosis: misunderstandings between epithelial cells and fibroblasts? Sarcoidosis Vasc Diffuse Lung Dis. 21:165–172. 2004.PubMed/NCBI
9	Acloque H, Adams MS, Fishwick K, et al: Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest. 119:1438–1449. 2009. View Article : Google Scholar : PubMed/NCBI
10	Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428. 2009. View Article : Google Scholar : PubMed/NCBI
11	Kalluri R and Neilson EG: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 112:1776–1784. 2003. View Article : Google Scholar : PubMed/NCBI
12	Zavadil J and Böttinger EP: TGF-beta and epithelial-to-mesenchymal transitions. Oncogene. 24:5764–5774. 2005. View Article : Google Scholar : PubMed/NCBI
13	Morali OG, Delmas V, Moore R, et al: IGF-II induces rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene. 20:4942–4950. 2001. View Article : Google Scholar : PubMed/NCBI
14	Strutz F, Zeisberg M, Ziyadeh FN, et al: Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int. 61:1714–1728. 2002. View Article : Google Scholar : PubMed/NCBI
15	Kasai H, Allen JT, Mason RM, et al: TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir Res. 6:562005. View Article : Google Scholar
16	Meuten T, Hickey A, Franklin K, et al: WNT7B in fibroblastic foci of idiopathic pulmonary fibrosis. Respir Res. 13:622012. View Article : Google Scholar : PubMed/NCBI
17	Guo Y, Xiao L, Sun L and Liu F: Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. Physiol Res. 61:337–346. 2012.PubMed/NCBI
18	Borok Z: Role for alpha3 integrin in EMT and pulmonary fibrosis. J Clin Invest. 119:7–10. 2009.
19	Selman M and Pardo A: Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc Am Thorac Soc. 3:364–372. 2006. View Article : Google Scholar : PubMed/NCBI
20	Lawson WE, Polosukhin VV, Stathopoulos GT, et al: Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin. Am J Pathol. 167:1267–1277. 2005. View Article : Google Scholar : PubMed/NCBI
21	Jiang D, Liang J, Campanella GS, et al: Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4. J Clin Invest. 120:2049–2057. 2010. View Article : Google Scholar : PubMed/NCBI
22	Jiang D, Liang J, Hodge J, et al: Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest. 114:291–299. 2004. View Article : Google Scholar : PubMed/NCBI
23	Moon RT, Kohn AD, De Ferrari GV and Kaykas A: WNT and β-catenin signalling: diseases and therapies. Nat Rev Genet. 5:691–701. 2004. View Article : Google Scholar : PubMed/NCBI
24	Bao XL, Song H, Chen Z and Tang X: Wnt3a promotes epithelial-mesenchymal transition, migration, and proliferation of lens epithelial cells. Mol Vis. 18:1983–1990. 2012.PubMed/NCBI
25	Gauldie J, Bonniaud P, Sime P, et al: TGF-beta, Smad3 and the process of progressive fibrosis. Biochem Soc Trans. 35:661–664. 2007. View Article : Google Scholar : PubMed/NCBI
26	Moeller A, Ask K, Warburton D, et al: The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol. 40:362–382. 2008. View Article : Google Scholar
27	Moore BB and Hogaboam CM: Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 294:L152–L160. 2008. View Article : Google Scholar
28	Lewis CC, Yang JY, Huang X, et al: Disease-specific gene expression profiling in multiple models of lung disease. Am J Respir Crit Care Med. 177:376–387. 2008. View Article : Google Scholar
29	Levänen B, Wheelock AM, Eklund A, et al: Increased pulmonary Wnt (wingless/integrated)-signaling in patients with sarcoidosis. Respir Med. 105:282–291. 2011. View Article : Google Scholar
30	Biernacka A, Dobaczewski M and Frangogiannis NG: TGF-β signaling in fibrosis. Growth Factors. 29:196–202. 2011. View Article : Google Scholar : PubMed/NCBI
31	Carre AL, James AW, MacLeod L, et al: Interaction of wingless protein (Wnt), transforming growth factor-beta1, and hyaluronan production in fetal and postnatal fibroblasts. Plast Reconstr Surg. 125:74–88. 2010. View Article : Google Scholar : PubMed/NCBI
32	Sato M: Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids. Acta Derm Venereol. 86:300–307. 2006. View Article : Google Scholar : PubMed/NCBI
33	Cheon SS, Nadesan P, Poon R and Alman BA: Growth factors regulate beta-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing. Exp Cell Res. 293:267–274. 2004. View Article : Google Scholar : PubMed/NCBI
34	Izumo T, Kondo M and Nagai A: Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis. Eur Respir J. 34:1444–1451. 2009. View Article : Google Scholar : PubMed/NCBI
35	Robb WB, Condron C, Moriarty M, et al: Taurine attenuates radiation-induced lung fibrosis in C57/Bl6 fibrosis prone mice. Ir J Med Sci. 179:99–105. 2010. View Article : Google Scholar
36	Jiang C, Huang H, Liu J, et al: Fasudil, a rho-kinase inhibitor, attenuates bleomycin-induced pulmonary fibrosis in mice. Int J Mol Sci. 13:8293–8307. 2012. View Article : Google Scholar : PubMed/NCBI